Clinical Trial Update: Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of RXC004 in patients with advanced malignancies; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• RXC004

Snippet

Sponsor: Redx Pharma Ltd | Conditions: Cancer, Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2025-01-29